RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTIONS trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA vaccine aims to shield against RSV
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new mRNA vaccine called IN006 to see if it is safe and helps the body fight RSV, a common virus that can cause serious breathing problems. About 200 healthy adults aged 18 to 79 will receive one or two shots of the vaccine or a placebo. Researchers will monitor…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase: PHASE1 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 30, 2026 15:48 UTC
-
Bogotá study tests RSV prevention for newborns
Prevention Not yet recruitingThis study looks at how well two RSV prevention methods work in real life for babies under 6 months in Bogotá. One method is a vaccine given to pregnant women, and the other is an antibody shot given to newborns whose mothers didn't get the vaccine. Researchers will compare how m…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Sponsor: Bogotá District Health Secretariat • Aim: Prevention
Last updated Apr 29, 2026 15:01 UTC